Jointly steered by healthcare and life sciences heads Mathilde Merckx and Xavier Lebrasseur, the team at ALCHIMIE AVOCATS provides particular expertise in anti-gift issues and data protection matters within the healthcare, pharmaceuticals and biotech sectors.

A&O Shearman has a comprehensive healthcare and life sciences offering, allowing the team to advise clients across the pharmaceuticals, finance, biotech, medtech and healthcare sectors. Typical mandates for the team include M&A transactions, infringement lawsuits, patent litigation and regulatory data protection advice. Laëtitia Bénard, who spearheads the practice, is an experienced litigator, well regarded in the market for her expertise in handling multi-jurisdictional and national patent disputes for major pharmaceutical companies. Charles Tuffreau brings strong expertise in validity and infringement issues, advising clients across the full remit of cross-border litigation and preliminary injunction proceedings.

ADVANT Altana is home to an experienced healthcare and life sciences team whose varied case load ranges from M&A transactions to IP protection and contractual matters, with the team showcasing a strong track record in litigation, including pharmaceutical anti-competition and regulatory non-compliance cases. The practice group is co-led by Armand Aviges, a seasoned litigator in product liability matters, particularly complex serial claims, and Jean-Nicolas Soret, who focuses on private cross-border M&A transactions in the biotech and medtech industries. Gilles Gaillard is a name to note for clients seeking advice on corporate finance transactions, acquisitions or disposals of assets.

One of the pre-eminent law firms in France for healthcare and life sciences, Dechert LLP is regularly instructed by pharmaceutical and biotechnology companies, as well as laboratories and nursing homes. Clients regularly turn to the team for assistance with regulatory compliance, pricing matters, product liability complaints, and complex life sciences and pharmaceutical litigation. Co-heading the practice, Mélanie Thill-Tayara is an experienced litigator, well-known in the market for handling antitrust and competition matters at EU and French level for major life sciences, pharmaceutical and healthcare clients, while Alain Decombe’s broad expertise extends across the full remit of corporate transactions. Sophie Pelé has in-depth knowledge of litigation in strategic market access cases.

A pre-eminent healthcare and life sciences firm, Dentons is regularly turned to by pharmaceutical companies, biotech and medtech firms, and healthcare providers. Led by Jean-Marc Grosperrin, Julien Le Guyader and Anne-Laure Marcerou, the department continues to advise on M&A transactions, marketing rights, regulatory advice, patent protection and FTO analyses. Grosperrin is regularly sought after by international pharmaceutical groups, while Le Guyader specialises in licensing and market access issues, and Marcerou provides expertise in representing foreign and domestic private equity funds engaging in life sciences investments. Jessica Garestier stands out for her work across the full remit of regulatory matters.

With a particularly active healthcare and life sciences practice, Hogan Lovells (Paris) LLP’s team is recognised for its expertise in matters relating to competition law, regulatory compliance, healthcare data processing, product liability and commercial litigation. At the helm of the practice, Mikael Salmela covers the entire scope of the product lifecycle in the pharmaceutical, biotech and medical device sectors, undertaking matters ranging from advising on clinical trial frameworks to negotiating high-value commercial agreements. Charlotte Damiano is regularly called upon by clients for regulatory and market access matters, as well as representing pharmaceutical and medical device companies in pricing and reimbursement disputes.

McDermott Will & Schulte’s healthcare and life sciences practice spans an array of sectors, including biotech, biopharmaceuticals, medtech and venture capital. The team is recognised for its expertise in R&D collaboration and licensing agreements, M&A transactions, and cross-border regulatory pathways work. The department is under the leadership of Emmanuelle Trombe, who is well regarded for the depth of her expertise in advising on joint ventures and strategic collaborations in both France and the United States. Anthony Paronneau advises on a wide array of corporate finance transactions and corporate securities.

Simmons & Simmons’ wide-ranging practice encompasses regulatory compliance, M&A and contract negotiation, with a noted expertise in pharmaceutical product liability. The practice is jointly led by experienced partners Jacques-Antoine Robert and Alexandre Regniault. Robert has a high level of experience and knowledge in the pharmaceutical industry, acting for clients in regulatory matters, transactions and disputes. Regniault is a reference for pharmaceutical, medical device and biotech clients across the full range of contentious and non-contentious matters, from licensing negotiations to breach of contract litigation. Ombline Ancelin stands out for her work in competition law, while Simonetta Giordano specialises in joint ventures and commercial contracts.

August Debouzy maintains an active presence in the healthcare and life sciences sector, with the team standing out for its experience in complex intellectual property issues, particularly patent litigation. The group is led by the capable quartet of François Pochart, Grégoire Desrousseaux, Lionel Martin and Hélène Billery. Pochart is an experienced patent litigator, regularly representing clients before the domestic courts and the UPC. Desrousseaux is a name to note in EPO litigation and licensing issues, while Martin specialises in matters within the medical devices industry. Billery frequently assists pharmaceutical and biotechnology clients on regulatory and compliance issues.

Baker McKenzie’s wide-ranging healthcare and life sciences practice encompasses regulatory compliance, M&A transactions, and licensing and contractual matters across the biotech, medical devices, pharmaceuticals and healthcare sectors. Spearheading the practice, Julie Yeni covers a broad scope of work, which ranges from advising on regulatory procedures in clinical trials to market access matters. Marie-Françoise Bréchignac advises on a wide range of multi-jurisdictional corporate transactions, while Ludivine Naulleau is prepared to handle the full lifecycle of health products, from medical devices to cosmetics, including marketing authorisation and pharmaceutical licensing. Melodie Truong and Marion de Galembert are key figures within the team.

Bird & Bird's healthcare and life sciences team is jointly steered by Emmanuelle Porte and Anne-Charlotte Le Bihan. The group is recognised for its expertise in IP and patent litigation, advising companies across the biotech, medtech, digital health and technology sectors. The team’s strategic transactions capabilities are also noteworthy. Porte has established experience handling venture capital, M&A and corporate finance transactions, as well as advising clients on the structuring of joint ventures. Le Bihan brings significant experience in both contentious and non-contentious IP matters to the team, in particular, specialising in pan-European patent litigation within the pharmaceutical industry. Johanna Harelimana has broad experience, extending from clinical trial and market access matters to regulatory advice on phytopharmaceuticals.

De Gaulle Fleurance & Associés is home to a highly experienced healthcare and life sciences team, whose cross-practice approach draws on the firm’s wider strengths in IP, IT, data protection, competition, and AI to advise clients across the biopharmaceutical, animal health, pharmaceutical, digital tech and medtech sectors. The practice is co-headed by experienced practitioners Jean-Marie Job, Cécile Théard-Jallu and Francine Le Péchon-Joubert. Job is a reference for pharmaceutical and biotechnology clients regarding regulatory compliance, market access and contractual matters. Théard-Jallu is well versed in complex R&D and consortium contractual transactions, while Le Péchon-Joubert specialises in defending trademark portfolios.

Delsol Avocats’ healthcare and life sciences team is particularly impressive in handling health data issues, including gaining authorisations from the CNIL and managing consortium health data warehouse matters. The firm is also skilled in advising on anti-corruption frameworks and regulatory compliance. The practice group is co-headed by experienced practitioners Jeanne Bossi Malafosse, who specialises in personal data protection matters, and Gaëlle Merlier, who is well known in the market for advising pharmaceutical companies, medical device manufacturers and clinical laboratories on M&A transactions. Aura Braun advises on a wide array of regulatory issues.

DLA Piper continues to handle instructions from clients in the pharmaceuticals, financial services, medical devices, laboratory and healthtech sectors. The team’s wide-ranging expertise encompasses M&A transactions, drafting and negotiating strategic agreements, and advising on the full remit of regulatory issues. Spearheading the practice, Sonia De Kondserovsky is well known in the market for transactional matters ranging from acquisitions of listed and non-listed companies to corporate restructurings. Guillaume-Denis Faure is an experienced healthcare litigator, regularly representing clinics, hospitals and laboratories, while Denise Lebeau-Marianna specialises in regulatory compliance matters, particularly strategic data governance projects.

Fieldfisher is home to a highly experienced healthcare and life sciences team, catering to clients across the biocontrol, digital health, pharmaceutical and medtech sectors. The firm’s work covers transactional, regulatory, and contentious matters, ranging from involvement in AI-driven clinical research to complex pharmaceutical litigation and M&A transactions. Leading the team, Olivier Lantrès is well known in the market for litigation in highly regulated sectors. Nathalie Hadjadj-Cazier stands out for her strategic advice on, and defence of, IP rights. Marguerite Brac de la Perrière left the firm in March 2026.

Gide Loyrette Nouel A.A.R.P.I. has a comprehensive healthcare and life sciences offering, allowing the team to advise on financing, capital markets, IP, M&A transactions and competition law. Raphaëlle Dequiré-Portier is an experienced litigator, specialising in domestic and pan-European patent and trademark disputes. Paul Jourdan-Nayrac specialises in cross-border M&A and private equity matters, while Arnaud Duhamel brings an in-depth knowledge of debt capital markets and strategic equity derivatives transactions. Farah El-Bsat is also noted for her expertise in complex project finance and venture debt financing for biotech and medtech companies.

Cross-border IP litigation is at the heart of HOYNG ROKH MONEGIER’s healthcare and life sciences practice. The practice continues to handle instructions from clients in the pharmaceutical, biotech, medical devices and biopharmaceutical sectors. The group is under the joint leadership of Benoît Strowel and Anne Servoir: Strowel is an experienced litigator in both France and Belgium who excels in multi-jurisdictional patent litigation, while Servoir showcases strong credentials in competition law and regulatory matters within the pharmaceutical and biotech industries. Sabine Agé is a reference for biotech, pharmacy, chemistry and medical devices clients.

jasper Avocats' practice spans an array of industries, including medtech, pharmaceutical, medical software, hospital and health products. The team’s varied case load ranges from undertaking due diligence relating to fund raisings and acquisitions, to health product and medical liability litigation. The practice group is co-led by experienced partners Olivier Saumon, who specialises in pharmaceutical law, health product regulation and EU distribution law, and Céline Roquelle-Meyer, who focuses on medical biology matters, particularly governance structures. Jean-François Laigneau has a high level of experience and knowledge in the health products industry.

LexCase’s wide-ranging healthcare and life sciences practice encompasses product liability litigation, regulatory compliance issues, market access matters and marketing rights negotiations. The group is led by a capable quartet: Diane Bandon-Tourret, Alain de Belenet, Raphaël Apelbaum and Maxime Büsch. Bandon-Tourret combines significant experience in the pharmaceutical sector with wide-ranging expertise encompassing regulatory issues and litigation. De Belenet excels in public contract law and market access matters, while Apelbaum specialises in alternative dispute resolution in relation to public health procurement contracts. Büsch is a name to note for litigation relating to the liability of public entities.

Norton Rose Fulbright’s healthcare and life sciences team is jointly steered by Marta Giner Asins and Karine Montagut, with the team’s varied case load including regulatory compliance, antitrust matters, and digital and data privacy issues. Asins is a reference for pharmaceutical clients, acting in both major litigation and M&A transactions. Montagut regularly advises domestic and international clients on acquisitions and disposals, while Christian Dargham leads the firm’s disputes practice on matters concerning product liability. Nadège Martin is recommended for handling cross-border data privacy issues.

Reed Smith maintains a strong position in the healthcare and life sciences market, with the team’s wide-ranging expertise encompassing product liability litigation, competition compliance risk assessments and tender disputes. The group is co-headed by Natasha Tardif, Marc Lévy and Daniel Kadar. Tardif has strong credentials in advising on competition law issues within the pharmaceutical sector, as well as advising on merger notifications. Lévy specialises in antitrust litigation and competition compliance, while Kadar stands out for his work in complex litigation and cross-border disputes.

Winston & Strawn LLP has a comprehensive healthcare and life sciences offering, allowing the team to advise on PE-backed M&A transactions, strategic partnerships, regulatory litigation and the full remit of contractual matters. The practice group is co-led by experienced partners Gilles Bigot, who specialises in strategic litigation, cybersecurity issues in healthcare and public-private partnerships, and Julie Vern Cesano-Gouffrant, who is noted for the depth of her expertise in complex domestic and cross-border transactions. Rim Khirddine is frequently sought out by health care facilities, clinics, and assisted living communities to advise on regulatory compliance.

BCTG Avocats’ cross-functional healthcare and life sciences practice encompasses regulation, competition, distribution and intellectual property matters across the pharmaceutical, medtech, biotech and OTC product laboratory sectors. François Dauba showcases expertise in drafting and negotiating commercial contracts for pharmaceutical clients, while Hugues Villey-Desmeserets regularly represents clients before professional associations and criminal courts. Gaëlle Bloret-Pucci is an experienced IP litigator, and Séverin Kullmann advises domestic and international clients on private equity transactions.

Clifford Chance’s healthcare and life sciences group handles a wide array of litigation, involving product liability, IP, antitrust and employment disputes. The practice also continues to assist clients in navigating regulatory matters, ranging from advertising to anti-gift matters. Marianne Pezant is a key contact for domestic and international corporations, private equity firms and financial institutions seeking advice on strategic M&A and private equity transactions. Laurent Schoenstein showcases in-depth knowledge of governance and regulatory constraints pertinent to consolidated groups of medical practitioners, while David Tayar is an experienced antitrust litigator. Health data expert Patrice Navarro is also a name to note.

Goodwin is home to a highly experienced healthcare and life sciences team, capable of advising clients on strategic acquisitions, joint ventures, fundraising and cross-border transactions. Spearheading the team, Anne-Charlotte Rivière specialises in venture capital, M&A and private equity transactions. Marie Fillon is a name to note for strategic partnerships, including licences, collaborations, and distribution agreements. Maxence Bloch brings in-depth knowledge of M&A transactions, in particular leveraged buyouts and private equity transactions.

Structuring transactions and negotiating and drafting commercial and transactional agreements are at the heart of HBC Avocats’ healthcare and life sciences practice. The practice group is co-led by experienced partners Jonathan Burnham, who has a high level of experience and knowledge in licensing, partnership and clinical trial agreements, and Erwan Cossé, who specialises in M&A and venture capital transactions. Fabrice Herbin is also a key name to note.

Jones Day is home to an experienced healthcare and life sciences group, led by Françoise Labrousse and Renaud Bonnet. Typical mandates for the team include M&A transactions, regulatory compliance analysis, and the protection and defence of intellectual property assets. Labrousse regularly defends clients facing regulatory enforcement actions, while Bonnet leads the team on venture capital, private equity and M&A matters. Thomas Bouvet is an experienced litigator specialising in supplementary protection certificates and standard essential patents.

Latham & Watkins’ healthcare and life sciences team demonstrates wide-ranging expertise, encompassing private equity, M&A and regulatory compliance matters, as well as antitrust and data protection litigation. Leading the team, Eveline Van Keymeulen is well regarded for the depth of her expertise in key strategic legal and policy developments relating to the EU regulatory framework. Olivier du Mottay showcases strong credentials in M&A matters, in particular international private equity transactions and leveraged acquisitions.

Linklaters’ wide-ranging practice encompasses M&A transactions, IP and product liability litigation, cybersecurity matters and foreign investment control advice. Pauline Debré is noted for the depth of her expertise in patent and trademark litigation, acting for clients before the national courts and the UPC. Gaëlle Bourout regularly advises biotech and pharmaceutical clients on patent issues, while Pierre Tourres specialises in public and private M&A transactions and corporate restructurings. Thomas Elkins has a high level of experience and knowledge in antitrust and foreign investment matters.

Magenta’s practice spans an array of industries, including the pharmaceutical, medtech, and cosmetics sectors. The team is recognised for its expertise in handling competition law, regulatory compliance and financial matters, ranging from market access to reimbursement issues. Gaël Hichri has a high level of experience and knowledge in competition and distribution law, frequently acting for clients in matters of anti-competitive and restrictive practices. Benjamin Jothy is a name to note for public procurement and concession contracts.

Mercure Avocats' healthcare and life sciences practice is jointly steered by François-Maxime Philizot and Agathe Simon, with the group advising clients across the biotech, cosmetics, pharmaceuticals and medical devices sectors. Philizot is a notable contact for regulatory issues within the pharmaceutical and medical devices sectors. Simon has in-depth knowledge of matters ranging from acquisition and joint venture agreements to sellers’ warranties.

Pinsent Masons LLP’s comprehensive practice encompasses patent litigation, regulatory advice, R&D collaborations, and M&A tax structuring, with the team operating across the pharmaceutical, biotech, cosmetics and medtech sectors. Camille Chiari is a name to note for domestic and cross-border private equity transactions, while Annabelle Richard covers the entire scope of data protection and cybersecurity matters. Virginia de Freitas excels in IP matters, in particular pan-European patent litigation.

Taylor Wessing has a comprehensive healthcare and life sciences offering, allowing the team to advise on biotech, pharmaceutical and medical device patent disputes, as well as clinical trials agreements and market access matters. The department is under the leadership of Evelyne Friedel, who specialises in regulatory matters within the pharmaceutical industry. Marine Boullenger is a name to note for compliance programs and contract law, while Marc Schuler excels in data management matters. Jules Fabre joined the firm from Pinsent Masons LLP in May 2025, bringing strong expertise in domestic and cross-border patent and SPC litigations.

Viguié Schmidt & Associés' healthcare and life sciences team demonstrates particular expertise in the pharmaceuticals, biotech and biopharmaceutical sectors. The team continue to showcase strength in advising on product liability litigation, antitrust matters and regulatory issues. Leading the team, Etienne Gouesse is well regarded for the depth of his expertise in both contentious and non-contentious matters, regularly representing clients in the administrative, civil and commercial courts. Iñaki Saint-Esteben is well known for his knowledge of antitrust law and advising on merger control matters.

Bignon Lebray‘s practice spans an array of industries, including pharmaceuticals, biotechnology, medical devices, diagnostics, and healthtech. Spearheading the practice from Lyon, Barbara Bertholet provides expertise on regulatory constraints and product distribution matters, while Nicolas Moreau specialises in advising clients on R&D and data privacy issues. Caroline Cazaux brings strong credentials in competition and antitrust issues, as well as the distribution of health products.

EY Société d'Avocats is home to a highly experienced healthcare and life sciences team whose practice spans an array of industries, including medical devices, biopharmaceuticals, health insurance and research. The practice group is co-led by seasoned partners Virginie Lefebvre-Dutilleul, Guillaume Pezzali and Caroline Mercier-Havsteen. Lefebvre-Dutilleul advises on a wide array of strategic advisory and regulatory issues, from designing regulatory roadmaps to supply contracts. Pezzali strengthens the firm’s M&A capabilities, while Mercier-Havsteen excels in domestic and cross-border litigation, with specific expertise in product liability matters in the pharmaceutical sector.

Ginestié Magellan Paley-Vincent is frequently called upon by healthcare professionals and public and private healthcare institutions seeking advice on negotiating practice agreements and managing disputes. Leading the team, Nathalie Boudet-Gizardin showcases expertise in licensing, telemedicine arrangements and professional liability litigation. Fabienne Kerebel is a name to note for M&A transactions, while Camille Faour specialises in regulatory and ethical matters.

Covering the entire scope of healthcare and life sciences matters, LERINS is able to advise clients on M&A transactions, digital health matters, regulatory compliance, and civil litigation. Luc Castagnet, who spearheads the practice, is well versed in acquisitions, consolidations, mergers, and the formation of specialised structures in the healthcare sector. Bertrand Vorms leads on contractual and civil litigation matters, while Bruno Lorit specialises in issues relating to regulatory authorities and health insurance institutions.

NOOA Avocats is praised by clients for its ‘deep sector knowledge and strong cross-border capability’. The firm’s practice spans an array of industries, with the team representing pharmaceutical groups, medical device manufacturers, biotechnology companies and cosmetics manufacturers. At the helm of the practice, Marie Sanchez’s expertise ranges from advising on regulatory issues and compliance matters such as market access, to representing clients before the French civil, commercial and administrative courts as well as the European Court of Justice.

Osborne Clarke is frequently instructed by clients across the medtech, biotech and pharmaceutical sectors, advising on matters ranging from market access to ethical and compliance programs. Spearheading the practice, Thomas Devred’s wide-ranging expertise encompasses regulatory and contractual issues, licensing and product distribution matters. Léa Masson-Boukobza is particularly skilled in compliance and regulatory issues within the pharmaceuticals and digital healthcare industries.

Product Law Firm’s practice spans an array of industries, including pharmaceutical, medical devices, cosmetics and healthcare. Typical mandates for the team range from product liability litigation to clinical trial regulation and contract drafting. Paul-Henry Devèze advises on a wide array of matters concerning health product regulation, including market access, commercial agreements and product withdrawal. Antoine de Brosses regularly acts for clients in the pharmaceutical sector on regulatory and medicinal product classification matters.

Patent litigation and regulatory disputes work is at the heart of Schertenleib’s healthcare and life sciences practice, with the team acting for clients across the pharmaceutical, medical devices and cosmetics industries. Spearheading the team, Denis Schertenleib excels in multinational litigation, in particular IP matters. Ombeline Degèze-Péchade’s extensive expertise encompasses complex regulatory frameworks and covert market strategies, while Marc Lauzeral is a name to note for cross-border patent and SPC disputes.

Squire Patton Boggs‘ well-established client base includes companies in the pharmaceuticals, biotechnology, medical devices, digital health and research sectors. The practice group is co-led by experienced partners Carole Sportes, who specialises in investment treaty claims, commercial arbitration and M&A, and Valérie Ravit, who focuses on insurance and product liability litigation. Charles Fabry is a name to note for management incentive schemes, joint ventures and corporate restructurings.

Intellectual property law is at the heart of Taliens’ healthcare and life sciences practice, with the team advising on patent protection, regulatory compliance, and IP lifecycle management. Co-heading the firm, Jean-Frédéric Gaultier is noted for the depth of his expertise in patent infringement proceedings, while Grégoire Triet regularly advises on cross-border patent enforcement and market entry matters. Tougane Loumeau is a name to note for SPC proceedings and pharmaceutical patent litigation.

UGGC Avocats' healthcare and life sciences team specialises in advising private and public health facilities on the production and distribution of health products, as well as showcasing expertise in advising on health regulations, contracts and regulatory litigation. Sylvie Welsch has a high level of experience and knowledge regarding contract and medical liability disputes. Malka Marcinkowski is well versed in both advisory and contentious competition and distribution matters within the medicines, cosmetic and medical devices sectors. Alison Leroy is a name to note for the management of IP rights, R&D contracts, and regulatory matters.